A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects ...

A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi ...

Chinechendo Eze is a Nigerian microbiologist and biotechnologist with research focuses on how to genetically engineer crops to enhance growth and resilience. She is a doctoral student and a graduate ...

Faculty, students and postdocs hoping to attend Columbus’ first multicultural STEM conference was halted by a federal ...

Announced increased focus on type 1 diabetes and in vivo CAR T programsRegulatory interactions increase confidence in moving forward with GMP ...

Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached $119 billion in ...

Planning to initiate an open-label Phase 2 study of TNX-1500 under an investigator-initiated IND to evaluate safety and activity in the first half of 2026 ...

Syndax’s leadership in menin inhibition and CSF-1R inhibition – – Revumenib abstracts showcase compelling results in multiple acute leukemia subtypes across the R/R, frontline, and post-HSCT setting – ...

Prelude Therapeutics Incorporated (Nasdaq: PRLD) (“Prelude” or the “Company”), a clinical-stage precision oncology company, ...

Additionally, the more than 50 abstracts accepted at ASH include new and updated data from Incyte’s MPN, GVHD and hematology ...

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficacy ...

The table below comprises the names of units which are part of the latest syllabus for the 2025 exams. These chapters are intact with minor additions. Discovery of Electron, Proton, and Neutron, ...